Sarissa Consulting LLC Meridian Bioscience Inc Transaction History
Sarissa Consulting LLC
- $96.9 Million
- Q3 2022
A detailed history of Sarissa Consulting LLC transactions in Meridian Bioscience Inc stock. As of the latest transaction made, Sarissa Consulting LLC holds 18,267 shares of VIVO stock, worth $0. This represents 0.59% of its overall portfolio holdings.
Number of Shares
18,267Holding current value
$0% of portfolio
0.59%Shares
1 transactions
Others Institutions Holding VIVO
# of Institutions
10Shares Held
113KCall Options Held
0Put Options Held
0-
Havens Advisors LLC New York, NY26.8KShares$02.29% of portfolio
-
Telemetry Investments, L.L.C. New York, NY20.3KShares$01.06% of portfolio
-
Advisor Partners LLC Walnut Creek, CA19.7KShares$00.04% of portfolio
-
Brinker Capital Investments, LLC16KShares$00.01% of portfolio
-
Hightower 6 M Holding, LLC11.8KShares$00.03% of portfolio
About MERIDIAN BIOSCIENCE INC
- Ticker VIVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 43,748,000
- Description
- Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...